STOCK TITAN

Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Perrigo (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced that CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present at the virtual Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference on June 10 at 9 AM ET.

Perrigo is a pure-play self-care company operating primarily in North America and Europe, specializing in over-the-counter (OTC) healthcare products. The company's business model combines store brand private label offerings with branded products including Opill®, Mederma®, Compeed®, EllaOne®, and Solpadeine®.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PRGO

+0.61%
1 alert
+0.61% News Effect

On the day this news was published, PRGO gained 0.61%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN, May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 10 at 9 AM ET.

Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.

About Perrigo

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Solpadeine®.

For more information, visit www.perrigo.com.

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's presentation at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995', as amended. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factors—many of which beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Investor Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications; (269) 686-3373; e-mail: bradley.joseph@perrigo.com

Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications; (269) 686-3238, e-mail: nicholas.gallagher@perrigo.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-to-attend-the-oppenheimer-25th-annual-consumer-growth--e-commerce-conference-302464287.html

SOURCE Perrigo Company plc

FAQ

When is Perrigo (PRGO) presenting at the Oppenheimer Consumer Conference 2025?

Perrigo will present at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference on Tuesday, June 10, 2025, at 9 AM ET.

Who will represent Perrigo (PRGO) at the Oppenheimer Conference 2025?

President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will represent Perrigo at the conference.

What are Perrigo's (PRGO) main consumer brands?

Perrigo's main consumer brands include Opill®, Mederma®, Compeed®, EllaOne®, and Solpadeine®.

What is Perrigo's (PRGO) business model?

Perrigo operates a unique business model that leverages cash-generative store brand private label offerings to fuel investments in leading consumer healthcare brands.
Perrigo Co Plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Latest SEC Filings

PRGO Stock Data

1.95B
137.02M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2